OPTOMED OY
Desconocido
Smartscope-X: Affordable accessible and automatic screening solution for diabetic retinopathy
OPTOMED OY
tramitó un
H2020:
H2020-SMEInst-2016-2017
Diabetes is a growing global health concern, affecting 422M people today and the number is projected to rise to 642M by
2040. Over 30 % of d...
2017-07-25 - 2021-04-30 | Financiado
2017-07-25 - 2021-04-30 | Financiado
SKINDETECTOR: Application of the innovative data fusion based non invasive approach for management of the diabetes...
OPTOMED OY
participó en un
FP7:
Diabetes mellitus (DM) is a heterogeneous group of disorders characterized by a high serum glucose level and by disturbances of carbohydrate...
Financiado
Financiado
* No se disponen de datos de la empresa actual.